Respiratory Multiple Rapid Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2, influenza A virus, influenza B virus, respiratory syncytial virus (RSV) or Adenovirus in Saliva or nasal swab specimens.The device detects any combination of the above viruses. Antigen tests are generally used for acute phase of infection, this test detects the antigen in specimen from individuals who are suspected of relative virus infection within 7 days of symptom onset. This test only provides an aid to diagnosis of novel coronavirus (SARS-CoV-2), influenza A virus, influenza B virus, RSV and Adenovirus infection. The infection status should be determined in combination with other diagnostic information such as PCR tests or medical image science, exposures and medical history.
